S&P 500   5,117.95 (+0.43%)
DOW   39,014.20 (+0.05%)
QQQ   442.92 (+0.89%)
AAPL   178.10 (-1.47%)
MSFT   412.56 (-0.26%)
META   498.64 (+1.74%)
GOOGL   137.77 (-0.50%)
AMZN   177.88 (+0.63%)
TSLA   200.82 (-0.53%)
NVDA   818.50 (+3.46%)
NIO   5.83 (+1.39%)
AMD   199.56 (+3.65%)
BABA   74.89 (+1.16%)
T   16.95 (+0.12%)
F   12.45 (+0.08%)
MU   95.47 (+5.36%)
CGC   3.27 (-0.61%)
GE   158.44 (+0.99%)
DIS   111.34 (-0.22%)
AMC   4.40 (+1.85%)
PFE   26.58 (+0.08%)
PYPL   60.62 (+0.46%)
XOM   106.14 (+1.55%)
S&P 500   5,117.95 (+0.43%)
DOW   39,014.20 (+0.05%)
QQQ   442.92 (+0.89%)
AAPL   178.10 (-1.47%)
MSFT   412.56 (-0.26%)
META   498.64 (+1.74%)
GOOGL   137.77 (-0.50%)
AMZN   177.88 (+0.63%)
TSLA   200.82 (-0.53%)
NVDA   818.50 (+3.46%)
NIO   5.83 (+1.39%)
AMD   199.56 (+3.65%)
BABA   74.89 (+1.16%)
T   16.95 (+0.12%)
F   12.45 (+0.08%)
MU   95.47 (+5.36%)
CGC   3.27 (-0.61%)
GE   158.44 (+0.99%)
DIS   111.34 (-0.22%)
AMC   4.40 (+1.85%)
PFE   26.58 (+0.08%)
PYPL   60.62 (+0.46%)
XOM   106.14 (+1.55%)
S&P 500   5,117.95 (+0.43%)
DOW   39,014.20 (+0.05%)
QQQ   442.92 (+0.89%)
AAPL   178.10 (-1.47%)
MSFT   412.56 (-0.26%)
META   498.64 (+1.74%)
GOOGL   137.77 (-0.50%)
AMZN   177.88 (+0.63%)
TSLA   200.82 (-0.53%)
NVDA   818.50 (+3.46%)
NIO   5.83 (+1.39%)
AMD   199.56 (+3.65%)
BABA   74.89 (+1.16%)
T   16.95 (+0.12%)
F   12.45 (+0.08%)
MU   95.47 (+5.36%)
CGC   3.27 (-0.61%)
GE   158.44 (+0.99%)
DIS   111.34 (-0.22%)
AMC   4.40 (+1.85%)
PFE   26.58 (+0.08%)
PYPL   60.62 (+0.46%)
XOM   106.14 (+1.55%)
S&P 500   5,117.95 (+0.43%)
DOW   39,014.20 (+0.05%)
QQQ   442.92 (+0.89%)
AAPL   178.10 (-1.47%)
MSFT   412.56 (-0.26%)
META   498.64 (+1.74%)
GOOGL   137.77 (-0.50%)
AMZN   177.88 (+0.63%)
TSLA   200.82 (-0.53%)
NVDA   818.50 (+3.46%)
NIO   5.83 (+1.39%)
AMD   199.56 (+3.65%)
BABA   74.89 (+1.16%)
T   16.95 (+0.12%)
F   12.45 (+0.08%)
MU   95.47 (+5.36%)
CGC   3.27 (-0.61%)
GE   158.44 (+0.99%)
DIS   111.34 (-0.22%)
AMC   4.40 (+1.85%)
PFE   26.58 (+0.08%)
PYPL   60.62 (+0.46%)
XOM   106.14 (+1.55%)

Ventas (VTR) Stock Price, News & Analysis

$43.48
+1.19 (+2.81%)
(As of 11:33 AM ET)
Today's Range
$42.24
$43.67
50-Day Range
$42.29
$50.95
52-Week Range
$39.33
$50.99
Volume
649,416 shs
Average Volume
2.37 million shs
Market Capitalization
$17.50 billion
P/E Ratio
N/A
Dividend Yield
4.14%
Price Target
$51.54

Ventas MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
21.6% Upside
$51.54 Price Target
Short Interest
Healthy
1.92% of Shares Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-2.06
Upright™ Environmental Score
News Sentiment
1.10mentions of Ventas in the last 14 days
Based on 14 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
7.94%
From $3.15 to $3.40 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.57 out of 5 stars

Finance Sector

147th out of 868 stocks

Real Estate Investment Trusts Industry

26th out of 178 stocks


VTR stock logo

About Ventas Stock (NYSE:VTR)

Ventas Inc. (NYSE: VTR) is a leading S&P 500 real estate investment trust focused on delivering strong, sustainable shareholder returns by enabling exceptional environments that benefit a large and growing aging population. The Company's growth is fueled by its senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments. Ventas leverages its unmatched operational expertise, data-driven insights from its Ventas Operational InsightsTM platform, extensive relationships and strong financial position to achieve its goal of delivering outsized performance across approximately 1,400 properties. The Ventas portfolio is composed of senior housing communities, outpatient medical buildings, research centers and healthcare facilities in North America and the United Kingdom. The Company benefits from a seasoned team of talented professionals who share a commitment to excellence, integrity and a common purpose of helping people live longer, healthier, happier lives.

VTR Stock Price History

VTR Stock News Headlines

Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Wells Fargo Downgrades Ventas (VTR)
Key Takeaways From Ventas Analyst Ratings
VTR Mar 2024 47.500 call
Digital Realty's (DLR) Q4 FFO & Revenues Miss Estimates
Ventas, Inc. (NYSE:VTR) Q4 2023 Earnings Call Transcript
Rare Earth Elements: The Workhorse of The Tech Revolution
They're the most underrated yet crucial elements of technology. From renewable energy to military defense, Rare Earths are essential pieces of modern technology. Global superpowers and savvy investors are quickly learning just how valuable they truly are.
Pfizer's Expansion Sparks Boom for these Healthcare REITs
Q4 2023 Ventas Inc Earnings Call
Decoding Ventas Inc (VTR): A Strategic SWOT Insight
Ventas' (VTR) Q4 FFO Meets Estimates, Revenues Rise Y/Y
Ventas Q4 Loss Widens
Ventas (VTR) Q4 FFO Match Estimates
Healthcare REIT Ventas reports rise in Q4 FFO
Healthcare REIT Ventas reports rise in Q4 FFO
Is a Beat in the Offing for Ventas (VTR) in Q4 Earnings?
See More Headlines
Receive VTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ventas and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/09/2023
Ex-Dividend for 1/18 Dividend
12/29/2023
Dividend Payable
1/18/2024
Today
3/01/2024
Next Earnings (Estimated)
5/13/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Finance
Industry
Real estate investment trusts
Sub-Industry
Specialized REITs
CUSIP
92276F10
Employees
486
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$51.54
High Stock Price Target
$60.00
Low Stock Price Target
$46.00
Potential Upside/Downside
+21.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
12 Analysts

Profitability

Net Income
$-40,970,000.00
Pretax Margin
-2.57%

Debt

Sales & Book Value

Annual Sales
$4.50 billion
Cash Flow
$3.24 per share
Book Value
$23.72 per share

Miscellaneous

Free Float
397,230,000
Market Cap
$17.02 billion
Optionable
Optionable
Beta
1.29

Social Links

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

Should I Buy Ventas Stock? VTR Pros and Cons Explained

These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Ventas was last updated on Tuesday, February 27, 2024 at 3:01 PM.

Pros

Here are some ways that investors could benefit from investing in Ventas, Inc.:

  • Ventas, Inc. has a strong dividend yield of 4.05%, providing investors with a steady income stream.
  • The company's stock price has shown resilience, with a 1-year high of $51.29, indicating potential for capital appreciation.
  • Ventas has a diversified portfolio in the healthcare REIT sector, which can provide stability and growth opportunities.
  • Positive analyst ratings and target price upgrades suggest confidence in Ventas's future performance.
  • Institutional investors hold a significant stake in Ventas, indicating trust and confidence in the company's prospects.

Cons

Investors should be bearish about investing in Ventas, Inc. for these reasons:

  • Ventas's debt-to-equity ratio of 1.36 may pose a risk, as higher debt levels can impact financial stability and flexibility.
  • The company's current ratio and quick ratio of 0.43 each raise concerns about liquidity and ability to meet short-term obligations.
  • Market volatility and economic uncertainties can affect the performance of real estate investment trusts like Ventas.
  • Recent selling of Ventas shares by institutional investors may indicate a lack of confidence in the company's future prospects.
  • The company's price-to-earnings ratio of 4,451.45 may suggest an overvaluation, warranting caution for potential investors.














VTR Stock Analysis - Frequently Asked Questions

Should I buy or sell Ventas stock right now?

12 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Ventas in the last year. There are currently 3 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" VTR shares.
View VTR analyst ratings
or view top-rated stocks.

What is Ventas' stock price target for 2024?

12 Wall Street analysts have issued twelve-month target prices for Ventas' shares. Their VTR share price targets range from $46.00 to $60.00. On average, they anticipate the company's share price to reach $51.54 in the next twelve months. This suggests a possible upside of 21.6% from the stock's current price.
View analysts price targets for VTR
or view top-rated stocks among Wall Street analysts.

How have VTR shares performed in 2024?

Ventas' stock was trading at $49.84 at the beginning of the year. Since then, VTR stock has decreased by 15.0% and is now trading at $42.37.
View the best growth stocks for 2024 here
.

Are investors shorting Ventas?

Ventas saw a increase in short interest during the month of January. As of January 31st, there was short interest totaling 8,690,000 shares, an increase of 14.3% from the January 15th total of 7,600,000 shares. Based on an average daily volume of 2,080,000 shares, the short-interest ratio is presently 4.2 days.
View Ventas' Short Interest
.

When is Ventas' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 13th 2024.
View our VTR earnings forecast
.

How were Ventas' earnings last quarter?

Ventas, Inc. (NYSE:VTR) posted its earnings results on Thursday, February, 9th. The real estate investment trust reported ($0.11) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.72 by $0.83. The real estate investment trust had revenue of $1.05 billion for the quarter, compared to the consensus estimate of $1.04 billion. Ventas had a negative net margin of 0.91% and a negative trailing twelve-month return on equity of 0.41%. The company's revenue for the quarter was up 2.8% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.73 earnings per share.
Read the conference call transcript
.

How often does Ventas pay dividends? What is the dividend yield for Ventas?

Ventas announced a quarterly dividend on Tuesday, December 5th. Shareholders of record on Tuesday, January 2nd will be given a dividend of $0.45 per share on Thursday, January 18th. This represents a $1.80 dividend on an annualized basis and a dividend yield of 4.25%. The ex-dividend date is Friday, December 29th.
Read our dividend analysis for VTR
.

Is Ventas a good dividend stock?

Ventas (NYSE:VTR) pays an annual dividend of $1.80 per share and currently has a dividend yield of 4.19%. VTR has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for VTR.

What guidance has Ventas issued on next quarter's earnings?

Ventas issued an update on its FY 2024 earnings guidance on Wednesday, February, 14th. The company provided earnings per share guidance of 3.070-3.180 for the period, compared to the consensus EPS estimate of 3.210. The company issued revenue guidance of -.

What is Debra A. Cafaro's approval rating as Ventas' CEO?

20 employees have rated Ventas Chief Executive Officer Debra A. Cafaro on Glassdoor.com. Debra A. Cafaro has an approval rating of 89% among the company's employees.

What other stocks do shareholders of Ventas own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ventas investors own include AT&T (T), Verizon Communications (VZ), Realty Income (O), Coca-Cola (KO), Johnson & Johnson (JNJ), Enterprise Products Partners (EPD), Cisco Systems (CSCO), AbbVie (ABBV), Exxon Mobil (XOM) and Pfizer (PFE).

Who are Ventas' major shareholders?

Ventas' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (15.90%), Principal Financial Group Inc. (4.92%), Centersquare Investment Management LLC (1.74%), Legal & General Group Plc (1.58%), Dimensional Fund Advisors LP (1.46%) and Price T Rowe Associates Inc. MD (1.26%). Insiders that own company stock include Debra A Cafaro, Debra A Cafaro, Richard I Gilchrist, Robert F Probst and Walter C Rakowich.
View institutional ownership trends
.

How do I buy shares of Ventas?

Shares of VTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:VTR) was last updated on 3/1/2024 by MarketBeat.com Staff